Skip to main content
. 2016 Aug 10;13(9):673–679. doi: 10.7150/ijms.16175

Table 1.

Laboratory data of controls and patients with community-acquired pneumonia (CAP) before and after antibiotic treatment a, b

Clinical variable Controls
(n = 54)
CAP patients (n = 93) p value
Before treatment After treatment UT/C c UT/T d
Age (years) 59.57 ± 11.05 63.15 ± 20.98 0.247
Gender
Male 36 (66.7%) 56 (60.2%) 0.436
Female 18 (33.3%) 37 (39.8%)
CRP (mg/dl) 0.46 ± 0.27 11.26 ± 7.30 4.61 ± 4.65 < 0.001 < 0.001
WBCs (cells/mm3) 6280.7 ± 1814.5 12,505.4 ± 5533.9 8752.0 ± 3673.2 < 0.001 < 0.001
Neutrophils (cells/mm3) 3670.9 ± 1341.7 9904.1 ± 5010.1 6265.3 ± 3402.2 < 0.001 < 0.001
PSI score 82.97 ± 37.17
CURB-65 score 1.09 ± 0.93
APACHE II score 9.94 ± 5.31
Hospital length of stay (days) 11.71 ±17.49

CRP, C-reactive protein; WBCs, white blood cells; C, controls; UT, CAP patients before they received antibiotic treatment; T, CAP patients after they received antibiotic treatment; PSI, Pneumonia Severity Index; CURB-65, confusion, urea of > 7 mmol/l, respiratory rate of > 30/min, low systolic (< 90 mmHg) or diastolic (< 60 mmHg) blood pressure, and aged ≥ 65 years; APACHE, Acute Physiology and Chronic Health Evaluation.

a p < 0.05 was considered significant.

b Data were presented as the mean ± SD and n (%).

c The statistical difference was analyzed by the Mann-Whitney U-test.

d The statistical difference was analyzed by the Wilcoxon signed-rank test.

Figure 1 shows plasma OPN levels in control subjects and CAP patients before and after antibiotic treatment. CAP patients presented with significantly higher OPN plasma levels compared to control subjects (controls: 9.16 ± 5.61 ng/mL; patients: 24.32 ± 14.08 ng/mL; p < 0.001; Figure 1). After CAP patients received antibiotic treatment, OPN levels significantly dropped (untreated: 24.32 ± 14.08 ng/mL; treated: 16.50 ± 12.01 ng/mL; p < 0.001; Figure 1).